Skip To Main Content
Fuchs CS on Muck Rack

Fuchs CS

As seen in: Nature, Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Fuchs CS’s profile

Articles by Fuchs CS

Protracted complete response after limited checkpoint inhibitor dosing: A case report

|
By Quinne Sember, Darren Sigal, Fuchs CS, Jang RW
| Wiley Online Library Verified
1 INTRODUCTION Immunotherapy has emerged as an important treatment in many types of malignancy.
Open in Who Shared Issue with article?

Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)

|
By Wang QL, Wolpin BM, Fuchs CS, Guthrie KA
| ncbi.nlm.nih.gov
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Open in Who Shared View Duplicates (630) Issue with article?

Plasma 25-hydroxyvitamin D levels and survival in stage III colon cancer: Findings from CALGB/SWOG 80702 (Alliance)

|
By Wang QL, Fuchs CS, Wolpin BM, Guthrie KA
| ncbi.nlm.nih.gov
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Open in Who Shared View Duplicates (537) Issue with article?

Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial

|
By Ajani JA, D'Amico TA, Bentrem DJ, Fuchs CS
| Nature Verified
A randomised phase 2 trial of trimodality with or without induction chemotherapy (IC) in oesophageal cancer (EC) patients showed no advantage in overall survival (OS) or pathologic complete response rate. To identify subsets that might benefit from IC, a secondary analysis was done. The trial had accrued 126 patients (NCT 00525915). Recursive partitioning and proportional hazards regression with interactions were performed.
Open in Who Shared Issue with article?

A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer - PubMed

|
By Goldberg RM, Sargent DJ, Morton RF, Fuchs CS
| ncbi.nlm.nih.gov
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Open in Who Shared View Duplicates (613) Issue with article?
Show More